DSM Forms Joint Venture with North China

Puts Anti-Infective Assets in JV -- DSM, a large Dutch chemical and nutrition company, will carve out the anti-infectives part of its pharma business, putting these assets into a joint venture with North China Pharmaceutical Corporation. The move may be a precursor to a divestiture of the business in the future, though the immediate goal is to find additional business partners for the unit. DSM said it thinks this strategy holds the most promise over the long run. More details...